Trust Point Inc. Increases Stock Position in Encompass Health Co. (NYSE:EHC)

Trust Point Inc. raised its position in shares of Encompass Health Co. (NYSE:EHC) by 34.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,325 shares of the company’s stock after buying an additional 1,109 shares during the period. Trust Point Inc.’s holdings in Encompass Health were worth $399,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in EHC. MassMutual Private Wealth & Trust FSB boosted its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares during the period. UMB Bank n.a. boosted its position in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the period. V Square Quantitative Management LLC boosted its position in Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares during the period. Avior Wealth Management LLC purchased a new stake in Encompass Health during the 3rd quarter valued at $40,000. Finally, Tompkins Financial Corp purchased a new stake in Encompass Health during the 4th quarter valued at $46,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on EHC shares. Barclays raised their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. KeyCorp raised their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Trading Up 1.0 %

Shares of NYSE EHC opened at $102.18 on Thursday. Encompass Health Co. has a 1 year low of $71.79 and a 1 year high of $104.55. The stock has a market cap of $10.29 billion, a P/E ratio of 24.68, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. The firm has a 50-day moving average of $96.43 and a 200 day moving average of $95.08. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.